Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Total Current Liabilities: 2019-2025

Historic Total Current Liabilities for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to $44.2 million.

  • Eton Pharmaceuticals' Total Current Liabilities rose 123.89% to $44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.2 million, marking a year-over-year increase of 123.89%. This contributed to the annual value of $19.9 million for FY2024, which is 22.82% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Total Current Liabilities of $44.2 million as of Q3 2025, which was up 14.48% from $38.6 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Total Current Liabilities registered a high of $44.2 million during Q3 2025, and its lowest value of $3.1 million during Q2 2021.
  • Moreover, its 3-year median value for Total Current Liabilities was $18.2 million (2024), whereas its average is $20.5 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Total Current Liabilities decreased by 13.04% in 2022, and later skyrocketed by 151.52% in 2023.
  • Quarterly analysis of 5 years shows Eton Pharmaceuticals' Total Current Liabilities stood at $4.6 million in 2021, then surged by 41.75% to $6.5 million in 2022, then skyrocketed by 151.37% to $16.2 million in 2023, then rose by 22.82% to $19.9 million in 2024, then soared by 123.89% to $44.2 million in 2025.
  • Its Total Current Liabilities was $44.2 million in Q3 2025, compared to $38.6 million in Q2 2025 and $25.4 million in Q1 2025.